News
Novo Nordisk’s shock profit downgrade and 22% share price plunge spooked global markets. But for ResMed shareholders, the ...
Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...
After Mikayla Nogueira unveiled her 60-pound weight loss transformation, the TikToker cleared the air on how she accomplished ...
Dubai: Once upon a time, brunch in Dubai was simple. You’d sit there with your crispy Avo egg toast and someone would ...
Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
Novo Nordisk stock (NVO) (DK:NOVO.B) slumped 21.83% to fall to a new three-year low. It was the stock's worst daily loss since a 26.15% fall on Oct. 19, 1987. It's fallen 24.77% over the past two days ...
Novo, which became Europe’s most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as ...
The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.
Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook ...
Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
If you’ve spent any time in the real world lately, chances are you’ve heard of Ozempic, Wegovy, Mounjaro or semaglutide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results